Investors

Overview

Corporate Profile

Forward Pharma is a biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune disorders such as multiple sclerosis and psoriasis.

Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark, in the heart of Medicon Valley. Since 2007 we have also operated out of a subsidiary, Forward Pharma GmbH, in Leipzig, Germany, and since August 2014 out of a subsidiary in the United States, Forward Pharma USA, LLC.


Most Recent Presentation
Download Documentation JMP Securities Healthcare Conference

Stock Information
FWP (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Financial Status IndicatorC
Price$20.23
Change (%)0.00 (0.00%)
Volume0
Data as of 08/25/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: FWP.OQ.  Currently trading at $20.23 with a 52 week high of $29.12 and a 52 week low of $11.22.

Recent NewsMore >>
DateTitle 
06/06/16Forward Pharma CFO to Participate in Two Investor Conferences in June
COPENHAGEN, Denmark, June 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conferences: Jefferies Healthcare Conference to be held at the Grand Hyatt in New York, New York.  Mr. Sendek will p... 
Printer Friendly Version
06/02/16Forward Pharma Reports First Quarter 2016 Financial and Operational Results
COPENHAGEN, Denmark, June 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the first quarter ended March 31, 2016.  Net loss for the first quarter ended March 31, 2016 was $16.9 million, or $(0.36) per basic share versus net income of $6.0 million, or $0.13 per basic share for first quarter of 2015.  On a non-GAAP basis, after removing the effect of non-cash income and expense items, our first quarter net lo... 
Printer Friendly Version
05/09/16Forward Pharma Announces Board of Directors Expansion with Appointment of Two New Non-Executive Directors
COPENHAGEN, Denmark, May 09, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Karen Smith and Dr. Duncan Moore have been appointed to its Board of Directors as non-executive directors, expanding the Board to seven members.  Dr. Moore will also serve as a member of the Audit Committee.  The elections took place on May 6, 2016 at the Company's Annual General Meeting in Copenhagen. “I am very pleased that Forward Pharma has been able to continue... 
Printer Friendly Version
05/02/16Forward Pharma CFO to Present at the Deutsche Bank Health Care Conference
COPENHAGEN, Denmark, May 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and neurological indications, today announced that Joel Sendek, the Company’s Chief Financial Officer, will participate in the following conference:     Deutsche Bank Annual Health Care Conference to be held at the InterContinental Hotel in Boston, Massa... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
09/12/16
Forward Pharma A/S at Morgan Stanley Global Healthcare Conference
LocationThe Grand Hyatt
New York, NY
09/14/16
through
09/17/16
Forward Pharma A/S at ECTRIMS Congress
LocationLondon, UK
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Forward Pharma A/S posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources